This research project aims to sort out the product series in the field of cannabidiol (CBD), gain insight into the characteristics of the industry, the market stock space and the incremental space, and judge the position of various competitors in the field of cannabidiol (CBD) in combination with the market development prospects.
Cannabis is a general term for cannabis plants, and all cannabis contains tetrahydrocannabinol (THC) and cannabidiol (CBD). At present, the cannabis referred to internationally mainly refers to industrial hemp Hemp and medical hemp Marijuana. Although Hemp and Marijuana are both cannabis plants, the core difference lies in the THC content. The THC content of industrial hemp Hemp is less than 0.3%, and the THC content of medical hemp Marijuana is higher than 0.3%. In China, cannabis is only divided into industrial hemp and drug hemp, and industrial hemp is also called hemp (Hemp), and drug hemp is a drug and cannot be planted. CBD is the main chemical component in cannabis, mainly extracted from female cannabis plants. It is a non-addictive component in cannabis and has anti-inflammatory, bactericidal, analgesic, anti-anxiety, antipsychotic, antioxidant, learning and memory improvement, neuroprotection and reduced intestinal motility. In this report, all the data listed are mainly statistics of CBD extracts obtained from cannabis flowers and leaves, including CBD oil and CBD crystals.
The core manufacturers of cannabidiol (CBD) in the world include Aurora Cannabis, Charlotte's Web CBD, Endoca, Kazmira and KND Labs, etc. The top five manufacturers account for about 19% of the global market share. North America is the largest market, accounting for about 47% of the market share. In terms of product types, full-spectrum CBD oil is the largest segment, accounting for about 40% of the market share. At the same time, in terms of downstream, medicine is the largest downstream field, accounting for 58% of the market share.
Medical Atomization Technology + California-Based Manufacturing Breaks Trade Barriers and Reshapes the Industry Against the backdrop of escalating U.S.-China trade tensions, the vaping industry faces unprecedented tariff pressures. Traditional vaping brands, reliant on Chinese supply chains, have seen costs surge and market competitiveness plummet. However, VPLUS has successfully navigated this challenge through forward-thinking strategies—leveraging 100% U.S.-made, California-produced water-soluble […]
Apr 18, 2025
This research project aims to sort out the product series in the field of cannabidiol (CBD), gain insight into the characteristics of the industry, the market stock space and the incremental space, and judge the position of various competitors in the field of cannabidiol (CBD) in combination with the market development prospects. Cannabis is a […]
Apr 10, 2025
A recent review by a Canadian research team suggests that cannabinoids could play a role in preventing and treating both COVID-19 and Long COVID. In a comprehensive assessment, Canadian scientists presented intriguing insights into the potential role of cannabinoids in combating SARS-CoV-2. The study, titled "Cannabinoids and the Endocannabinoid System in Early SARS-CoV-2 Infection and […]
Mar 26, 2025
CBD (cannabidiol), an important cannabinoid component of the cannabis plant, is a pharmacologically broad-spectrum drug that has attracted increasing attention in recent years as a treatment for a range of neuropsychiatric disorders. The potential of CBD as a treatment for depression-related disorders was determined by evaluating evidence from preclinical, human, clinical, and epidemiological studies. The […]
Mar 17, 2025
NFD, FDA, and NIH authoritatively endorse the medical value of cannabinoids: NFD survey results show that 96% of consumers who actively try to reduce the use of prescription drugs have been successful when using cannabis instead; with the passage of more favorable cannabis laws around the world, consumers are increasingly using cannabis to treat a […]
Mar 06, 2025